Thomas Smith
Stock Analyst at Leerink Partners
(1.28)
# 1253
Out of 5,298 analysts
103
Total ratings
30.16%
Success rate
14.00%
Average return
Main Sectors:
Top Industries:
Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
EQ Equillium | Downgrades: Market Perform | 3 1 | 0.47 | 112.77% | 4 | Mar 28, 2025 | |
QTTB Q32 Bio | Downgrades: Market Perform | 68 9 | 1.62 | 455.56% | 2 | Dec 11, 2024 | |
ACRS Aclaris Therapeutics | Upgrades: Outperform | 2 7 | 1.4 | 400% | 7 | Nov 19, 2024 | |
ALMS Alumis | Initiates Coverage On: Outperform | 29 | 10.05 | 188.56% | 1 | Jul 23, 2024 | |
RNAC Cartesian Therapeuti... | Initiates Coverage On: Outperform | 39 | 9.99 | 290.39% | 1 | Apr 23, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 42 65 | n/a | n/a | 2 | Apr 12, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 26 | 2.08 | 1150% | 1 | Mar 25, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 10 | 1.06 | 843.4% | 2 | Feb 21, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 33 | n/a | n/a | 2 | Feb 20, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 20 | 5.24 | 281.68% | 1 | Nov 14, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 30 17 | n/a | n/a | 3 | May 23, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 45 56 | n/a | n/a | 1 | Mar 8, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 430 435 | 554.62 | -21.57% | 3 | Mar 3, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 17 18 | n/a | n/a | 7 | Mar 3, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 36 | 41.28 | -12.79% | 1 | Feb 28, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 9 7 | 0.63 | 1011.11% | 4 | Feb 8, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 14 21 | 14.59 | 43.93% | 6 | Feb 6, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 40 45 | 12.03 | 274.06% | 2 | Jan 9, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 6 | 6.05 | -0.83% | 1 | Nov 22, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 16 19 | n/a | n/a | 2 | Nov 21, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 30 20 | n/a | n/a | 4 | Nov 11, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 5 6 | 4.75 | 26.32% | 2 | Nov 9, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 9 5 | 0.99 | 405.05% | 3 | Oct 21, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 46 77 | n/a | n/a | 1 | Oct 11, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 17 | 37.22 | -54.33% | 1 | Aug 25, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 55 60 | n/a | n/a | 5 | Aug 12, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 68 64 | 15.81 | 304.81% | 2 | Aug 9, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 66 70 | 17.3 | 304.62% | 5 | Aug 9, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 225 150 | n/a | n/a | 5 | Aug 3, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 50 29 | 5.75 | 404.35% | 5 | Jul 11, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 33 26 | 2.83 | 818.73% | 3 | Jun 1, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 13 12 | 0.32 | 3650% | 4 | May 12, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 18 12 | 22.66 | -47.04% | 2 | Apr 28, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 15 10 | 3.36 | 197.62% | 4 | Apr 11, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 675 400 | 2.55 | 15586.27% | 2 | Mar 16, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 42 80 | 10 | 700% | 2 | Dec 8, 2020 |